Motley Fool  Feb 2  Comment 
Shares rose in response to the release of upbeat clinical data from an important phase 2 study.
Motley Fool  Jan 10  Comment 
A presentation at the J.P. Morgan Healthcare Conference and update on 2017 guidance sent shares sharply lower. Is the market overreacting?
Motley Fool  Jan 6  Comment 
Shareholders took it on the chin, but the company continues to offer investors reasons to be optimistic.
Motley Fool  Jan 5  Comment 
These stocks defied mixed market performance to climb. Find out why.
Benzinga  Jan 5  Comment 
Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares are trading higher by $1.31 at $12.00 in Thursday's session. The issue spiked to $17.045 in pre-market trading but has come nowhere near that level during the regular session. The catalyst for...
Motley Fool  Jan 5  Comment 
Shares rise in response to a data release from an important Phase 2 study.
Benzinga  Jan 5  Comment 
Shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company focused on developing and commercializing novel oncology products that target tumor microenvironment, gained more than 10 percent Thursday morning. Investors and...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki